Dr. John Hosei Yim, MD

Dr. Yim practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Yim's NPI, 1598731820, was assigned on February 27, 2006. Dr. Yim graduated from Stanford University School Of Medicine in 1992. Dr. Yim holds California license G88325.

Dr. Yim's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Yim's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Yim is also affiliated with San Antonio Regional Hospital. The medical group on file is City of Hope. Dmand AI also links Dr. Yim to 1 more hospital and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yim practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Yim's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Yim is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Yim's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists breast reconstruction, collapsed lung, esophagus, stomach, or upper small intestine surgery, mastectomy and thyroid surgery among the conditions Dr. Yim treats.

CMS data shows 1,404 Medicare services from Dr. Yim across 11 procedure codes in 2024, for 484 Medicare patients. Medicare paid $99,830 for them.

CMS counts 484 Medicare patients who saw Dr. Yim in 2024. The largest group is 65 to 74, with 256 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yim's median patient age at 67, with 86% women.

In 2024, Dr. Yim wrote 353 Medicare Part D claims for 94 patients. 71% of them were for generic drugs. CMS names the drug for 303 of them, across 6 drugs with 11 or more claims each, at $9,137 in total drug cost. In 2023, CMS named 256 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Yim for performance year 2024, reported as part of a group. Dr. Yim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yim as offering telehealth.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 98 papers to Dr. Yim, published from 2006 to 2022. 2016 was the busiest year, with 9. The most frequent topics are Breast Neoplasms, Cell Line, Tumor and DNA-Binding Proteins. Dr. Yim has published most often in Surgery. Dr. Yim's most frequent co-authors are Joanne E. Mortimer, MD, Ernest S. Han, MD and Laura Kruper, MD.

Dmand AI links Dr. Yim to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Thyroid Neoplasms and Thyroid Diseases.

CMS Open Payments shows 28 general payments to Dr. Yim from 11 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 56% of the total. Corcept Therapeutics paid the most, $8,353.

Dmand AI lists 1 award for Dr. Yim.

Dr. Yim graduated from Stanford University School Of Medicine in 1992. Dr. Yim is a member of ACS.

Dr. Yim is in network with 13 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.